{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:12:22Z","timestamp":1793304742649,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ghir.2022.101467","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:45:39Z","timestamp":1652795139000},"page":"101467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly"],"prefix":"10.1016","volume":"64","author":[{"given":"Carolina","family":"Peixe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ghir.2022.101467_bb0005","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198501033120103","article-title":"Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor","volume":"312","author":"Melmed","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ghir.2022.101467_bb0015","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","article-title":"Acromegaly caused by secretion of growth hormone by a non-Hodgkin\u2019s lymphoma","volume":"342","author":"Beuschlein","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ghir.2022.101467_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2265.2011.04108.x","article-title":"Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility","volume":"75","author":"Arafat","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2022.101467_bb0030","first-page":"30","article-title":"Pitfalls of insulin-like growth factor I assays","volume":"71","author":"Bidlingmaier","year":"2009","journal-title":"Horm. Res."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20120663","article-title":"Insulin-like growth factor-I (IGF-I) and clinical nutrition","volume":"125","author":"Livingstone","year":"2013","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/eje.1.02131","article-title":"Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects","volume":"154","author":"Schneider","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1054\/clnu.2001.0397","article-title":"Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders","volume":"20","author":"Caregaro","year":"2001","journal-title":"Clin. Nutr."},{"issue":"2\u20133","key":"10.1016\/j.ghir.2022.101467_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2007-978716","article-title":"Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus","volume":"31","author":"Bereket","year":"1999","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0055","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2265.1994.tb02584.x","article-title":"Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus","volume":"41","author":"Clayton","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/adc.76.4.304","article-title":"Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis","volume":"76","author":"Taylor","year":"1997","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0899-9007(96)00399-1","article-title":"Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis","volume":"13","author":"Caregaro","year":"1997","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.krcp.2011.12.005","article-title":"The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities","volume":"31","author":"Oh","year":"2012","journal-title":"Kidney Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0075","first-page":"41","article-title":"Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society","volume":"26","author":"Lim","year":"2005","journal-title":"Clin. Biochem. Rev."},{"issue":"11","key":"10.1016\/j.ghir.2022.101467_bb0080","first-page":"3710","article-title":"Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes","volume":"82","author":"Fryburg","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1677\/joe.0.1360253","article-title":"Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats","volume":"136","author":"Lewitt","year":"1993","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0090","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1590\/2359-3997000000193","article-title":"Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?","volume":"60","author":"Rosario","year":"2016","journal-title":"Arch. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","article-title":"Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?","volume":"71","author":"Freda","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.20945\/2359-3997000000192","article-title":"Laboratory investigations in the diagnosis and follow-up of GH-related disorders","volume":"63","author":"Schilbach","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2022.101467_bb0110","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.4158\/EP161295.OR","article-title":"Discordance between Gh and Igf-1 Levels in Turkish acromegalic patients","volume":"22","author":"Cerit","year":"2016","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/jcem.86.1.7154","article-title":"The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy","volume":"86","author":"Peacey","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2022.101467_bb0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrendo.2012.101","article-title":"The changing face of acromegaly--advances in diagnosis and treatment","volume":"8","author":"Ribeiro-Oliveira","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.ghir.2022.101467_bb0125","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1210\/jcem.87.8.8658","article-title":"Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up","volume":"87","author":"Dimaraki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0130","first-page":"293","article-title":"Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease","volume":"62","author":"Mercado","year":"2004","journal-title":"Horm. Res."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11102-016-0735-0","article-title":"\"Micromegaly\": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era","volume":"19","author":"Butz","year":"2016","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cen.13129","article-title":"The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis","volume":"85","author":"Kanakis","year":"2016","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2265.2005.02233.x","article-title":"Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?","volume":"62","author":"Damjanovic","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.1993.tb02139.x","article-title":"Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly","volume":"38","author":"Dobrashian","year":"1993","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0155","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4158\/EP11324.OR","article-title":"Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone","volume":"18","author":"Subbarayan","year":"2012","journal-title":"Endocr. Pract."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4158\/EP13359.OR","article-title":"Evaluation of variables influencing the measurement of insulin-like growth factor-1","volume":"20","author":"Bancos","year":"2014","journal-title":"Endocr. Pract."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EJE-21-0024","article-title":"Clinical and hormonal findings in patients presenting with high IGF-1 and growth hormone suppression after oral glucose load: a retrospective cohort study","volume":"185","author":"Carosi","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2017.01.004","article-title":"Genetic aspects of pituitary adenomas","volume":"46","author":"Marques","year":"2017","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.ghir.2022.101467_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.743052","article-title":"Postoperative GH and degree of reduction in IGF-1 predicts postoperative hormonal remission in acromegaly","volume":"12","author":"Cardinal","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1227\/01.neu.0000431480.87160.84","article-title":"Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma","volume":"73","author":"Shin","year":"2013","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-10-0969","article-title":"Hypothesis: extra-hepatic acromegaly: a new paradigm?","volume":"164","author":"Neggers","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0029-1239522","article-title":"Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity","volume":"42","author":"Elias","year":"2010","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0195","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12020-018-1797-8","article-title":"Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicetre cohort, and review of the literature","volume":"63","author":"Briet","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2022.101467_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000486001","article-title":"Metabolic complications of acromegaly","volume":"49","author":"Mercado","year":"2018","journal-title":"Front. Horm. Res."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-17-0546","article-title":"Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study","volume":"178","author":"Dal","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0210","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cen.13129","article-title":"The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis","volume":"85","author":"Kanakis","year":"2016","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/clinem\/dgaa859","article-title":"Discordant GH and IGF-1 results in treated acromegaly: impact of GH cutoffs and mean values assessment","volume":"106","author":"Campana","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2022.101467_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/370692","article-title":"Spuriously elevated serum IGF-1 in adult individuals with delayed puberty: a diagnostic pitfall","volume":"2010","author":"Imran","year":"2010","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","article-title":"Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays","volume":"57","author":"Clemmons","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2022.101467_bb0230","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ghir.2018.03.003","article-title":"The effect of growth hormone on bioactive IGF in overweight\/obese women","volume":"40","author":"Dichtel","year":"2018","journal-title":"Growth Horm. IGF Res."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0235","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz118","article-title":"Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA","volume":"105","author":"Wegmann","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0240","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0245","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/edrv-12-4-424","article-title":"Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins","volume":"12","author":"Baumann","year":"1991","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0250","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1530\/EJE-13-0510","article-title":"Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency","volume":"169","author":"Ameri","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061376","article-title":"Regulation of GH and GH signaling by nutrients","volume":"10","author":"Caputo","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0260","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","article-title":"Glucocorticoids and the regulation of growth hormone secretion","volume":"9","author":"Mazziotti","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0265","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0270","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ecl.2005.07.006","article-title":"Sex-steroid control of the aging somatotropic axis","volume":"34","author":"Veldhuis","year":"2005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0275","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11102-013-0504-2","article-title":"Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies","volume":"17","author":"Stone","year":"2014","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11102-010-0236-5","article-title":"Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly?","volume":"13","author":"Vallette","year":"2010","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","article-title":"Sex steroids and the GH axis: implications for the management of hypopituitarism","volume":"31","author":"Birzniece","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.0.1480443","article-title":"Raloxifene lowers IGF-I levels in acromegalic women","volume":"148","author":"Attanasio","year":"2003","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0295","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1152\/ajpendo.00709.2006","article-title":"Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men","volume":"293","author":"Muniyappa","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0300","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ijir.2011.31","article-title":"IGF-1 levels are significantly correlated with patient-reported measures of sexual function","volume":"23","author":"Pastuszak","year":"2011","journal-title":"Int. J. Impot. Res."},{"issue":"10","key":"10.1016\/j.ghir.2022.101467_bb0305","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2012.188128","article-title":"Automated 22-kD growth hormone-specific assay without interference from Pegvisomant","volume":"58","author":"Manolopoulou","year":"2012","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0310","article-title":"Growth hormone: isoforms, clinical aspects and assays interference","volume":"4","author":"de Oliveira Longo Schweizer","year":"2018","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/1941738118782688","article-title":"The use and abuse of human growth hormone in sports","volume":"10","author":"Siebert","year":"2018","journal-title":"Sports Health"},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0320","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/er.2006-0052","article-title":"The growth hormone\/insulin-like growth factor-I axis in exercise and sport","volume":"28","author":"Gibney","year":"2007","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0325","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10253890701292168","article-title":"Growth hormone response to different consecutive stress stimuli in healthy men: is there any difference?","volume":"10","author":"Jezova","year":"2007","journal-title":"Stress"},{"issue":"8","key":"10.1016\/j.ghir.2022.101467_bb0330","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00007256-200333080-00005","article-title":"The exercise-induced growth hormone response in athletes","volume":"33","author":"Godfrey","year":"2003","journal-title":"Sports Med."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0335","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1152\/jappl.1974.37.6.826","article-title":"Kinetics of human growth hormone during submaximal exercise","volume":"37","author":"Lassarre","year":"1974","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0340","first-page":"229","article-title":"Time course of plasma growth hormone during exercise in humans at altitude","volume":"50","author":"Raynaud","year":"1981","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0345","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1152\/jappl.1999.87.2.498","article-title":"Impact of acute exercise intensity on pulsatile growth hormone release in men","volume":"87","author":"Pritzlaff","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0350","first-page":"641","article-title":"The impact of sex and exercise duration on growth hormone secretion","volume":"101","author":"Wideman","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"10","key":"10.1016\/j.ghir.2022.101467_bb0355","first-page":"3492","article-title":"Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men","volume":"81","author":"Schwarz","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jcem-68-1-141","article-title":"Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations","volume":"68","author":"Suikkari","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2022.101467_bb0365","first-page":"3591","article-title":"Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport","volume":"84","author":"Wallace","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ghir.2022.101467_bb0370","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/ijms18112441","article-title":"Neurotrophic and neuroregenerative effects of GH\/IGF1","volume":"18","author":"Bianchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2022.101467_bb0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ghir.2022.101467_bb0380","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/OAJSM.S11626","article-title":"Growth hormone doping: a review","author":"Sonksen","year":"2011","journal-title":"Open Access J. Sports Med."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0385","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrendo.2013.38","article-title":"Changes in pituitary function with ageing and implications for patient care","volume":"9","author":"Veldhuis","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0390","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","article-title":"Systematic review: the safety and efficacy of growth hormone in the healthy elderly","volume":"146","author":"Liu","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0395","article-title":"Somatic growth, aging, and longevity","volume":"3","author":"Bartke","year":"2017","journal-title":"MPJ Aging Mech. Dis."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0400","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.beem.2017.02.005","article-title":"GH and ageing: pitfalls and new insights","volume":"31","author":"Bartke","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000147167","article-title":"Does the physiological acromegaly of pregnancy benefit the fetus?","volume":"66","author":"Verhaeghe","year":"2008","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.ghir.2022.101467_bb0410","doi-asserted-by":"crossref","DOI":"10.4137\/CMED.S38201","article-title":"Multiple effects of growth hormone in the body: is it really the hormone for growth?","volume":"9","author":"Devesa","year":"2016","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0415","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MED.0b013e32834c800d","article-title":"Placental hormones and the control of maternal metabolism and fetal growth","volume":"18","author":"Newbern","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0420","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4103\/2230-8210.122608","article-title":"Pregnancy and pituitary disorders: challenges in diagnosis and management","volume":"17","author":"Laway","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2022.101467_bb0425","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ghir.2012.11.001","article-title":"Detecting and solving the interference of pregnancy serum, in a GH immunometric assay","volume":"23","author":"Dias","year":"2013","journal-title":"Growth Horm. IGF Res."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0430","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11102-016-0740-3","article-title":"Pregnancy and acromegaly","volume":"20","author":"Muhammad","year":"2017","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0889-8529(18)30149-X","article-title":"Growth hormone in adolescence. Normal and abnormal","volume":"22","author":"Cara","year":"1993","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.ghir.2022.101467_bb0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ghir.2015.11.005","article-title":"Atypical defects resulting in growth hormone insensitivity","volume":"28","author":"Wit","year":"2016","journal-title":"Growth Horm. IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0445","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000497214","article-title":"Growth hormone response to oral glucose load: from normal to pathological conditions","volume":"108","author":"Hage","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.ghir.2022.101467_bb0450","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1210\/jc.2007-1244","article-title":"Growth hormone suppression after an oral glucose load in children","volume":"92","author":"Misra","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0455","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1530\/EJE-12-0106","article-title":"Serum IGF1 and insulin levels in girls with normal and precocious puberty","volume":"166","author":"Sorensen","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2022.101467_bb0460","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1210\/jcem.86.7.7649","article-title":"Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study","volume":"86","author":"Chanson","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0465","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004728-199001000-00006","article-title":"Height of normal pituitary gland on MR imaging: age and sex differentiation","volume":"14","author":"Suzuki","year":"1990","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0470","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms19051308","article-title":"Insulin-Like Growth Factor (IGF) system in liver diseases","volume":"19","author":"Adamek","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ghir.2022.101467_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071447","article-title":"The role of growth hormone and insulin-like growth factor-I in the liver","volume":"18","author":"Takahashi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0480","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/ijms19051339","article-title":"Somatotropic axis dysfunction in non-alcoholic fatty liver disease: beneficial hepatic and systemic effects of hormone supplementation","volume":"19","author":"Cabrera","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1354750X.2016.1252949","article-title":"Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis","volume":"22","author":"Colombo","year":"2017","journal-title":"Biomarkers"},{"issue":"12","key":"10.1016\/j.ghir.2022.101467_bb0490","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/cncr.11002","article-title":"Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study","volume":"95","author":"Mazziotti","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ghir.2022.101467_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/240873","article-title":"Relationship between GH\/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation","volume":"2014","author":"Salso","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0500","first-page":"495","article-title":"Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis","volume":"15","author":"Zietz","year":"2003","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0505","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/ENDO:18:2:105","article-title":"The endocrine system in diabetes mellitus","volume":"18","author":"Alrefai","year":"2002","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0510","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03346747","article-title":"Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders","volume":"36","author":"Lupi","year":"2013","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0515","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0520","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/dme.12829","article-title":"C-reactive protein and insulin growth factor 1 serum levels during the menstrual cycle in adolescents with Type 1 diabetes","volume":"33","author":"Codner","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ghir.2022.101467_bb0525","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2018.02.035","article-title":"Efficacy of growth hormone treatment in children with type 1 diabetes mellitus and growth hormone deficiency-an analysis of KIGS data","volume":"198","author":"Bonfig","year":"2018","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030772","article-title":"Mini review\/commentary: growth hormone treatment in children with type 1 diabetes","volume":"20","author":"Bonfig","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.ghir.2022.101467_bb0535","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Melmed","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0540","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ghir.2014.09.002","article-title":"The complex relationship between obesity and the somatropic axis: the long and winding road","volume":"24","author":"Savastano","year":"2014","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2022.101467_bb0545","series-title":"Endotext, South Dartmouth (MA)","article-title":"Endocrine changes in obesity","author":"Sidhu","year":"2000"},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0550","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ghir.2014.12.005","article-title":"Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies","volume":"25","author":"Stanley","year":"2015","journal-title":"Growth Horm. IGF Res."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0555","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2013-1099","article-title":"Approach to testing growth hormone (GH) secretion in obese subjects","volume":"98","author":"Popovic","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2022.101467_bb0560","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1210\/jc.2009-1295","article-title":"Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity","volume":"94","author":"Makimura","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10 Suppl 4","key":"10.1016\/j.ghir.2022.101467_bb0565","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","article-title":"Free insulin-like growth factors in human obesity","volume":"44","author":"Frystyk","year":"1995","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ghir.2022.101467_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082614","article-title":"Altered GH-IGF-1 axis in severe obese subjects is reversed after bariatric surgery-induced weight loss and related with low-grade chronic inflammation","volume":"9","author":"Juiz-Valina","year":"2020","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0575","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2012-4247","article-title":"Clinical review: the human experience with ghrelin administration","volume":"98","author":"Garin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0580","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2009.06.010","article-title":"The role of gut hormones in the regulation of body weight and energy homeostasis","volume":"316","author":"Karra","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2022.101467_bb0585","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.pmbts.2015.10.009","article-title":"Burden of growth hormone deficiency and excess in children","volume":"138","author":"Fideleff","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0590","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1530\/EJE-18-0596","article-title":"Mechanisms in endocrinology: anorexia nervosa and endocrinology: a clinical update","volume":"180","author":"Stoving","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0595","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-13-0477","article-title":"Determinants of GH resistance in malnutrition","volume":"220","author":"Fazeli","year":"2014","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0600","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ghir.2007.07.009","article-title":"The growth hormone\u2013insulin-like growth factor-I axis in chronic kidney disease","volume":"18","author":"Mak","year":"2008","journal-title":"Growth Horm. IGF Res."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0605","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.krcp.2011.12.005","article-title":"The insulin-like growth factor system in chronic kidney disease: pathophysiology and therapeutic opportunities","volume":"31","author":"Oh","year":"2012","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.ghir.2022.101467_bb0610","first-page":"S106","article-title":"Derangements of the somatotropic hormone axis in chronic renal failure","volume":"58","author":"Tonshoff","year":"1997","journal-title":"Kidney Int. Suppl."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0615","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ki.1997.26","article-title":"Effect of chronic metabolic acidosis on the growth hormone\/IGF-1 endocrine axis: new cause of growth hormone insensitivity in humans","volume":"51","author":"Brungger","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0620","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-007-0527-x","article-title":"Growth hormone axis in chronic kidney disease","volume":"23","author":"Mahesh","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"9","key":"10.1016\/j.ghir.2022.101467_bb0625","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","article-title":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease","volume":"15","author":"Drube","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0630","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.ghir.2022.101467_bb0635","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/105072501753271734","article-title":"Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction","volume":"11","author":"Iglesias","year":"2001","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0640","first-page":"950","article-title":"Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins","volume":"76","author":"Miell","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2022.101467_bb0645","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/endo.132.2.7678799","article-title":"Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated","volume":"132","author":"Nanto-Salonen","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2022.101467_bb0650","article-title":"Growth hormone and insulin-like growth factor 1 affect the severity of Graves' disease","volume":"2017","author":"Di Cerbo","year":"2017","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0655","doi-asserted-by":"crossref","first-page":"651","DOI":"10.14310\/horm.2002.1577","article-title":"IGF1 deficiency in newly diagnosed Graves\u2019 disease patients","volume":"14","author":"Martin","year":"2015","journal-title":"Hormones"},{"issue":"6","key":"10.1016\/j.ghir.2022.101467_bb0660","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone\u2013insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","journal-title":"Endocr. Connect."},{"issue":"3","key":"10.1016\/j.ghir.2022.101467_bb0665","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1432-0436.1985.tb00316.x","article-title":"A dual effector theory of growth-hormone action","volume":"29","author":"Green","year":"1985","journal-title":"Differentiation"},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0670","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/ijms18051019","article-title":"Growth hormone resistance\u2014special focus on inflammatory bowel disease","volume":"18","author":"Soendergaard","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0675","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2005-2931","article-title":"Clinical features affecting final adult height in patients with pediatric-onset Crohn\u2019s disease","volume":"118","author":"Sawczenko","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ghir.2022.101467_bb0680","first-page":"37","article-title":"Endocrine and metabolic manifestations in inflammatory bowel disease","volume":"25","author":"Tigas","year":"2012","journal-title":"Ann. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ghir.2022.101467_bb0685","first-page":"529","article-title":"Endocrine dysfunction in children with Crohn's disease","volume":"3","author":"Chong","year":"1984","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"5","key":"10.1016\/j.ghir.2022.101467_bb0690","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40618-017-0784-x","article-title":"Deregulation of the growth hormone\/insulin-like growth factor-1 axis in adults with cystic fibrosis","volume":"41","author":"Pascucci","year":"2018","journal-title":"J. Endocrinol. Invest."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637422000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637422000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:31Z","timestamp":1761087151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637422000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":138,"alternative-id":["S1096637422000247"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2022.101467","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2022.101467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101467"}}